
0:34
Dr. Charles Mok presents a short YouTube talk explaining semaglutide (brands Ozempic for diabetes, Wegovy for obesity) and focusing on dosing behavior. He introduces the pharmacologic ideas of drug tolerance and "extinction intolerance," notes that maintenance doses can be about ten times higher than starting doses, and states that little additional weight loss typically occurs once maintenance dose is reached.










